Peroxisome proliferator‐activated receptor activity correlates with poor survival in patients resected for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Peroxisome proliferator‐activated receptor activity correlates with poor survival in patients resected for hepatocellular carcinoma

Published:2020-06-17 Issue:4 Volume:28 Page:327-335
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Pommergaard Hans‐Christian¹^ORCID,Preuss Hasselby Jane²,Linno Willemoe Gro²,Ralbovska Adela³,Arendtsen Rostved Andreas¹,Rasmussen Allan¹,Aagaard Schultz Nicolai¹,Hillingsø Jens¹,Nørgaard Larsen Peter¹,Kugler Jan‐Michael³

Affiliation:

1. Department of Surgical Gastroenterology and Transplantation, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

2. Department of Pathology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

3. Institute for Molecular and Cellular Medicine University of CopenhagenPanum Institute Copenhagen Denmark

Publisher

Wiley

Subject

Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhbp.745

Reference31 articles.

1. Sorafenib in Advanced Hepatocellular Carcinoma

2. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

3. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma

4. PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System

5. The nuclear receptor superfamily: The second decade

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic genomic alterations in patients undergoing liver resection for hepatocellular carcinoma;Molecular Biology Reports;2024-03-27

2. Roles of peroxisome proliferator‐activated receptors in hepatocellular carcinoma;Journal of Cellular and Molecular Medicine;2023-11-20

3. Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma;APMIS;2023-04-25

4. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of Actinidia chinensis Planch. Root Extract for Application in Hepatocellular Carcinoma;Evidence-Based Complementary and Alternative Medicine;2022-09-20

5. The impact of ALDH7A1 variants in oral cancer development and prognosis;Aging;2022-05-25